Ophthalmology Grand Rounds: Ocular Toxicity Course
| When |
May 17, 2024
7 a.m. to 8 a.m.
|
|---|---|
| Where |
When it's time, join your Webex meeting here. Phone (audio only): Mobile phone (one-touch): |
| Contact Information |
Course details
Grand rounds is mainly a case-based CME conference representing all areas of ophthalmology. Residents and fellows present common and uncommon cases with interesting clinical questions and a faculty moderator will facilitate the discussion. The aim of the conference is to educate the audience on clinical pearls, best practices, quality improvement, and examining the contemporary evidence.
Target audience: Ophthalmologists and ophthalmologists in training.
Topic: Ocular Toxicity Course
Speakers:
- Winston Chamberlain, M.D., Ph.D.
- Aiyin Chen, M.D.
- Julie Falardeau, M.D.
- Thomas Hwang, M.D.
- Eric Suhler, M.D.
Learning objectives
Participants will be able to:
- Recognize important ocular manifestations of side effects of systemic medications
- Develop appropriate screening strategies for ocular toxicities
- Understand the management approach for the ocular toxicities
Accreditation
Oregon Health & Science University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physician
Credits
OHSU School of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure to Learners
Presenters/Moderators
- Winston Chamberlain, M.D., Ph.D. - Is a consultant for Leo, Aslan, Oyster Point/Viatris, Neumora, Beyeonics, Pfizer, Kedrion, Santen, BrightStar, Immunogen and Glaukos for which Consulting Fees were received; Is on the Data and Safety Monitoring Board for Noveome for which Consulting Fees were received; Is an investigator for Kiwa, Regenero, Cambium, ReGenTree, Emmecell for which Grant Support was received.
- Aiyin Chen, M.D. - Nothing to Disclose
- Julie Falardeau, M.D. - Nothing to Disclose
- Thomas Hwang, M.D. - Nothing to Disclose
- Eric Suhler, M.D., MPH - Is an investigator for EyeGate/Alumis, Genentech/Roche and Acelyrin, for which Grant Support and consulting fees were received; Is a consultant for Kriya and Alumis for which Consulting Fees were received.
Program Planning Committee
- Hemakshi Adke - Nothing to Disclose
- Aiyin Chen, M.D. - Nothing to Disclose
- Julie Falardeau, M.D. - Nothing to Disclose
- Seema Gupta, M.D. - Nothing to Disclose
- Brooke Harkness, O.D. - Nothing to Disclose
- Thomas Hwang, M.D. - Nothing to Disclose
- Susan Minnieweather - Nothing to Disclose
- Afshan Nanji, M.D. - Participated in a one -time paid trial of equipment for Beyeonics for which Consulting Fees were received.
- Amanda Redfern, M.D. - Nothing to Disclose
- Leah Reznick, M.D. - Nothing to Disclose
- Daniel Tu, M.D., Ph.D. - Nothing to Disclose
- Lorri Wilson, M.D. - Nothing to Disclose